Sullivan
Microsoft has discontinued support for Internet Explorer. To access the Sullivan website, please install a modern browser like Microsoft Edge or Google Chrome.
Biotech/Pharma Spin-Outs: Investment Strategies in Advancing Characterized Assets
When: April 30, 2025
Location: LSX World Congress
 

London, UK

People: David E. Danovitch

David Danovitch moderated the panel titled "Biotech/Pharma Spin-Outs: Investment Strategies in Advancing Characterized Assets" at the LSX World Congress on April 30, 2025. David guided a dynamic conversation with investors and industry leaders on the rise of spin-outs as key drivers of innovation, focusing on how capital, strategic partnerships and risk management fuel their growth. The panel also explored how collaborations with established pharma companies and investor support help bring breakthrough therapies from concept to clinic.